Ameliora Wealth Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-7,937
Closed -$638K – 231
2025
Q2
$638K Sell
7,937
-194
-2% -$15K 0.23% 58
2025
Q1
$653K Sell
8,131
-466
-5% -$38.8K 0.25% 53
2024
Q4
$704K Buy
8,597
+49
+0.6% +$4.08K 0.26% 49
2024
Q3
$705K Buy
8,548
+139
+2% +$10.4K 0.29% 43
2024
Q2
$590K Sell
8,409
-4,432
-35% -$316K 0.27% 53
2024
Q1
$952K Hold
12,841
– – 0.43% 46
2023
Q4
$849K Buy
12,841
+3,313
+35% +$207K 0.42% 44
2023
Q3
$599K Hold
9,528
– – 0.36% 44
2023
Q2
$539K Buy
9,528
+5,247
+123% +$291K 0.33% 52
2023
Q1
$248K Buy
4,281
+4,031
+1,612% +$272K 0.14% 82
2022
Q4
$18.1K Buy
+250
New +$17.9K 0.01% 192

Other funds holding MET

Ameliora Wealth Management's MET Position: Q3 2025 in Review

Ameliora Wealth Management sold out of MetLife (MET) in Q3 2025, closing a stake of 7,937 shares — an estimated $638K sold.

Ameliora Wealth Management first reported a position in MET in Q4 2022 and held it in 11 quarters. The position peaked at $952K in Q1 2024. 1,369 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Ameliora Wealth Management reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Ameliora Wealth Management sold 7,937 MetLife shares in Q3 2025, an estimated $638K.
  • Ameliora Wealth Management first reported a position in MetLife in Q4 2022 and held it in 11 quarters.
  • Ameliora Wealth Management's MetLife position peaked at $952K in Q1 2024.
  • 1,369 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Ameliora Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.